NCT02524678View on ClinicalTrials.gov

Phase 1 Study(Additional) of URC102 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 5, 2015

Primary Completion Date

October 7, 2015

Study Completion Date

March 28, 2016

Conditions
Healthy
Interventions
DRUG

Placebo

DRUG

URC102

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical
All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY